1. Home
  2. RGP vs ENLV Comparison

RGP vs ENLV Comparison

Compare RGP & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$3.97

Market Cap

149.5M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.96

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
ENLV
Founded
1996
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.5M
149.0M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
RGP
ENLV
Price
$3.97
$0.96
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$7.00
$20.00
AVG Volume (30 Days)
249.9K
281.0K
Earning Date
04-08-2026
05-29-2026
Dividend Yield
6.85%
N/A
EPS Growth
79.14
N/A
EPS
N/A
N/A
Revenue
$452,006,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$0.43
52 Week High
$5.55
$7.64

Technical Indicators

Market Signals
Indicator
RGP
ENLV
Relative Strength Index (RSI) 37.62 30.16
Support Level $3.83 $1.00
Resistance Level $4.53 $1.26
Average True Range (ATR) 0.15 0.14
MACD -0.04 0.01
Stochastic Oscillator 11.89 4.69

Price Performance

Historical Comparison
RGP
ENLV

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: